Fate Therapeutics FATE
NASDAQ FATE
$2.07 +0.01 (+0.49%)
At close: Oct 21, 2026 · 4:00 PM EDT

Fate Therapeutics (FATE) Other Operating Expenses (2023 - 2024)

Updated

Fate Therapeutics' Other Operating Expenses was $14.74 million in Q4 2024.

Analysis

Fate Therapeutics (FATE) Other Operating Expenses (2023 - 2024) Analysis & Trends

  • In earlier years, Other Operating Expenses was $2 million in FY2023.
  • The Q4 2024 figure marks the lowest quarterly Other Operating Expenses since Q1 2023.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Eli Lilly 1,136.97 Bn 1,105.55 Bn 19.71 Bn
2 Johnson & Johnson 619.72 Bn 538.25 Bn 17.26 Bn
3 AbbVie 503.40 Bn 476.52 Bn 12.70 Bn
4 Merck 370.15 Bn 324.53 Bn 12.21 Bn
5 Novartis Ag 298.64 Bn 262.63 Bn 11.24 Bn
6 Astrazeneca 261.07 Bn 234.76 Bn 12.86 Bn
7 Amgen 237.00 Bn 192.40 Bn 7.24 Bn
8 Gilead Sciences 191.24 Bn 165.43 Bn 6.22 Bn
9 Pfizer 170.31 Bn 116.96 Bn 10.94 Bn
10 Fate Therapeutics 248.02 Mn 94.22 Mn -
Historic Data

Historic Data

Download Data
DateValue
Dec 31, 2024 14.74 Mn
Mar 31, 2023 2.00 Mn
API Access

Fate Therapeutics Other Operating Expenses API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=other-operating-expenses&ticker=FATE&period=max&api_key=YOUR_API_KEY